D174-0519 Screening compound: 4-(4-ethylphenyl)-3-(2-hydroxyphenyl)-5-[(pyridin-3-yl)methyl]-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-6-one

D174-0519 Screening compound: 4-(4-ethylphenyl)-3-(2-hydroxyphenyl)-5-[(pyridin-3-yl)methyl]-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-6-one
D174-0519 Screening compound: 4-(4-ethylphenyl)-3-(2-hydroxyphenyl)-5-[(pyridin-3-yl)methyl]-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-6-one alternative view

Chemical Structure Depiction of ChemDiv screening compound D174-0519
4-(4-ethylphenyl)-3-(2-hydroxyphenyl)-5-[(pyridin-3-yl)methyl]-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-6-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D174-0519

Molecular Formula

C25H22N4O2 (C25 H22 N4 O2)

Compound Name

4-(4-ethylphenyl)-3-(2-hydroxyphenyl)-5-[(pyridin-3-yl)methyl]-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-6-one

IUPAC name

4-(4-ethylphenyl)-3-(2-hydroxyphenyl)-5-[(pyridin-3-yl)methyl]-1H4H5H6H-pyrrolo[34-c]pyrazol-6-one

SMILES

CCc1ccc(C(c2c3[nH]nc2-c(cccc2)c2O)N(Cc2cnccc2)C3=O)cc1

InChI

InChI=1S/C25H22N4O2/c1-2-16-9-11-18(12-10-16)24-21-22(19-7-3-4-8-20(19)30)27-28-23(21)25(31)29(24)15-17-6-5-13-26-14-17/h3-14,24,30H,2,15H2,1H3,(H,27,28)/t24-/m0/s1

InChI Key

NULFYLHTXUTCDM-DEOSSOPVSA-N

MDL Number (MFCD)

MFCD07425343

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

410.48

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.610

Distribution Coefficient, logD

4.598

Water Solubility, LogSw

-3.60

Polar Surface Area

66.204

Acid Dissociation Constant (pKa)

8.97

Base Dissociation Constant (pKb)

2.92

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

16.00

D174-0519 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Antiviral Library (67538 compounds)

Nucleic Acid Ligands (8311 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with D174-0519 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D174-0519?
Check Price and Availability of D174-0519, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D174-0519 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D174-0519
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D174-0519
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D174-0519 available by request